RhumbLine Advisers
MRNA icon

RhumbLine Advisers’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$17.2M Buy
622,857
+25,390
+4% +$701K 0.01% 792
2025
Q1
$16.9M Buy
597,467
+72,464
+14% +$2.05M 0.02% 771
2024
Q4
$21.8M Sell
525,003
-20,902
-4% -$869K 0.02% 653
2024
Q3
$36.5M Sell
545,905
-40,087
-7% -$2.68M 0.03% 440
2024
Q2
$69.6M Sell
585,992
-2,900
-0.5% -$344K 0.07% 247
2024
Q1
$62.8M Buy
588,892
+4,761
+0.8% +$507K 0.06% 278
2023
Q4
$58.1M Sell
584,131
-3,281
-0.6% -$326K 0.06% 278
2023
Q3
$60.7M Buy
587,412
+6,127
+1% +$633K 0.07% 246
2023
Q2
$70.6M Buy
581,285
+124
+0% +$15.1K 0.08% 226
2023
Q1
$89.3M Sell
581,161
-7,394
-1% -$1.14M 0.11% 165
2022
Q4
$106M Buy
588,555
+12,421
+2% +$2.23M 0.14% 137
2022
Q3
$68.1M Buy
576,134
+5,675
+1% +$671K 0.1% 182
2022
Q2
$81.5M Buy
570,459
+16,608
+3% +$2.37M 0.12% 156
2022
Q1
$95.4M Buy
553,851
+25,931
+5% +$4.47M 0.12% 145
2021
Q4
$134M Buy
527,920
+17,074
+3% +$4.34M 0.16% 111
2021
Q3
$197M Buy
510,846
+164,555
+48% +$63.3M 0.27% 72
2021
Q2
$81.4M Buy
346,291
+26,740
+8% +$6.28M 0.11% 163
2021
Q1
$41.8M Buy
319,551
+1,766
+0.6% +$231K 0.06% 289
2020
Q4
$33.2M Sell
317,785
-3,795
-1% -$396K 0.05% 361
2020
Q3
$22.8M Buy
321,580
+3,205
+1% +$227K 0.04% 432
2020
Q2
$20.4M Buy
318,375
+86,381
+37% +$5.55M 0.03% 445
2020
Q1
$6.95M Buy
231,994
+40,959
+21% +$1.23M 0.01% 836
2019
Q4
$3.74M Buy
191,035
+20,837
+12% +$408K 0.01% 1439
2019
Q3
$2.71M Buy
170,198
+137,924
+427% +$2.2M 0.01% 1562
2019
Q2
$472K Buy
32,274
+16,495
+105% +$241K ﹤0.01% 2385
2019
Q1
$321K Buy
+15,779
New +$321K ﹤0.01% 2508